Form 4: Cassava Sciences Director Buys Shares
Insider Transaction (Form 4)
Robert Eugene Anderson Jr, a Director of Cassava Sciences Inc, purchased 19,000 shares of common stock on November 18, 2026 for $0.52 per share.
Summary
- Open-market purchase: acquired 19,000 Common Stock at $0.52 ($9,880) on November 18, 2026; holds 27,600 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $9,880, committing personal capital to the stock.
Insider Transactions
Robert Eugene Anderson Jr — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-18 | Open-market purchase | Common Stock | 19,000 | $1 | $9.9K | 27,600 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-18 | Open-market purchase (19,000 shares) |
Keywords
insider transaction, Form 4, FLNA, FILANA THERAPEUTICS, INC., bullish, Robert Eugene Anderson Jr
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.